Skip to main content

Clinical Trials & Studies

If you are being treated in the NHS you may be asked to take part in a clinical study.

Clinical trials are research studies that involve patients or healthy people and are designed to test new treatments. A clinical study is research using human participants to help experts learn about different medical conditions and treatments. There are two primary types of clinical studies: clinical trials and observational studies. Both are designed to help health care professionals expand their knowledge of viable treatment—or preventative—options for patients, including medications, medical devices, surgery techniques, and therapies (e.g. radiation). Clinical studies may also focus on the development of diagnostic tools to help detect or prevent diseases and other medical conditions.

Clinical studies are important for discovering new treatments for diseases, as well as new ways to detect, diagnose, and reduce the chance of developing the disease. Clinical trials can show researchers what does and doesn’t work in humans that cannot be learned in the laboratory or in animals. Clinical trials also help doctors decide if the side effects of a new treatment are acceptable when weighed against the potential benefits.

Clinical trials aim to:

  • Find the best ways to prevent disease and reduce the number of people who become ill
  • Treat illness to improve survival or increase the number of people cured
  • Improve the quality of life for people living with illness, including reducing symptoms of disease or the side effects of other treatments, such as cancer chemotherapy
  • Diagnose diseases and health problems.

While clinical trials are important, the choice to participate in one is very personal and depends on your unique situation. You and your doctor need to weigh the benefits against the risks and decide what’s best for you, when presented with a clinical trial. 


What Clinical Trials are we currently running?



The RELIEF trial is looking at whether such a combined inhaler is better for treating mild asthma symptoms than a blue inhaler. The aim is to see whether use of this combined inhaler might lead to fewer asthma exacerbations for participants 💊👨‍⚕️

Asthma is a common, inflammatory condition of the airways, affecting approximately 10% of adults in the UK. Around 160,000 people a year receive an asthma diagnosis. This is more than are diagnosed with any other lung condition.

Patients aged 18+ with a clinical diagnosis of mild asthma can participate. Contact the practice and book an appointment with our respiratory nurse Chloe to enroll now! or visit for more information.


Observational study in atrial fibrillation (AF OR Atrial Flutter) patients at high risk of stroke - CHA2DS2-VASc > 2. The GARDENIA registry will collect real-world clinical data on the anticoagulant strategies in patients with AF at elevated risk of stroke but also elevated risk of bleeding.



A phase III study to assess efficacy and safety of N-Acetyl-GED-0507-34-LEVO gel 5%, applied once daily for 12 weeks in patients with acne vulgaris.

Patient aged >9 and <50 are eligible to participate.


Synexus Obesity Trial 

Do you struggle with weight-related health issues? Synexus is enrolling adults 18 years+ with a high Body Mass Index (BMI) and weight-related health issues such as cardiovascular disease (CVD) and Chronic Kidney Disease (CKD) for clinical trials assessing investigational medication on obesity and heart disease.

By volunteering for this trial, you can help to advance this important research for generations to come. 

If eligible to participate, you may reiieve compensation for your time and reimbursement for travel expenses. Call 02920 764455 and quote reference: 11117730


What Clinical Studies are we currently running?


Elsa Study

The ELSA study is screening children, aged 3-13 years to find out their risk of type 1 diabetes.

This is a simple finger stick blood test, you can do at home or in the community (school, general practice).

Children at high risk can be monitored and could enter research studies aiming to delay the start of type 1 diabetes. Every family who takes part is helping us to understand more about type 1 diabetes.

For more information, please see the online information tool here:

You can contact them by email: or phone: 0121 414 7814.


Treat To Target

Do you suffer from gout? Would you like to help us to find out what is the best way to treat flares of gout?  Then you may be interested in taking part in the Treat to target in gout research study (T2T).

The T2T study is looking at the most effective and cost-effective way to treat flares of gout. If you have gout you may be able to take part. If you would like to find out more information please contact Keele University Clinical Trials Unit on 01782 732950 or email:


MyMelanoma Study

The MyMelanoma Research Study is designed to answer the most important unanswered questions in melanoma research. This study is open to anyone who has ever been diagnosed with a melanoma of the skin, mucosal surfaces (e.g. nose, genitals) or under the nails.

For more information on this study, and to take part if eligible, simply visit